June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Comparison of pain and comfort for intravitreal administration of anti-VEGF agents using blepharostat vs non blepharostat techniques.
Author Affiliations & Notes
  • Jose Ramon Ramon Mier
    Ophtalmology, ISSSTE, MERIDA, Yucatan, Mexico
  • David Magana
    Retina, CIDOCS / UAS, Culiacán , Sinaloa, Mexico
    Ophtalmology, ISSSTE, MERIDA, Yucatan, Mexico
  • Efrain Romo-Garcia
    Retina, CIDOCS / UAS, Culiacán , Sinaloa, Mexico
    Ophtalmology, ISSSTE, MERIDA, Yucatan, Mexico
  • Wilehaldo Quiñónez
    Retina, CIDOCS / UAS, Culiacán , Sinaloa, Mexico
    Ophtalmology, ISSSTE, MERIDA, Yucatan, Mexico
  • Alonso Meza
    Ophtalmology, ISSSTE, MERIDA, Yucatan, Mexico
  • Gilberto Noe Gutierrez Ruiz
    Ophtalmology, ISSSTE, MERIDA, Yucatan, Mexico
  • Footnotes
    Commercial Relationships   Jose Ramon Mier, None; David Magana, None; Efrain Romo-Garcia, None; Wilehaldo Quiñónez, None; Alonso Meza, None; Gilberto Noe Gutierrez Ruiz, None
  • Footnotes
    Support  NONE
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 211. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Jose Ramon Ramon Mier, David Magana, Efrain Romo-Garcia, Wilehaldo Quiñónez, Alonso Meza, Gilberto Noe Gutierrez Ruiz; Comparison of pain and comfort for intravitreal administration of anti-VEGF agents using blepharostat vs non blepharostat techniques.. Invest. Ophthalmol. Vis. Sci. 2017;58(8):211.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Compare patients pain and comfort on both techniques with blepharostat and non blepharostat, to choose the comfortable, safe and adequate technique for the patient intravitreal administration of anti-VEGF.

Methods : Patients eligible for intravitreal administration of anti-VEGF agents due to various types of retinal diseases were interrogated to assess pain and comfort,using blepharostat vs non-blepharostat with appropriate aseptic techniques and Antisepsis prior iodine instillation 5%. To evaluate pain, we are using the numerical scale of pain score 0-10 (0 = no pain - 5 = moderate pain, 10 = worst pain). In addition, signs of cataract, inflammation or infection were sought immediately and at 28 days

Results : Intravitreal administration without blepharostat was less painful and more comfortable for patients, also in both groups were not found signs of cataract secondary to intravitreal administration, infectious or inflammatory signs.

Conclusions : Adequate intravitreal administration of anti-VEGF technique without blepharostat is less painful, more comfortable and safe for the patient than using a blepharostat technique.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×